Niagen Bioscience, Inc. Common Stock

Shares of Niagen Bioscience, Inc. Common Stock (NAGE) are trading at $3.45. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (22.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place NAGE at a fair price relative to peers.

Technical & fundamental data as of Jun 16, 2026.